Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

CAR-T Therapy for the Treatment of Relapsed/Refractory CD19 Positive Large B Cell Lymphoma: Canadian Real-World Evidence

Xiu Xia Sherry Tan, Melissa Maltez, Ranjeeta Mallick, Linda Hamelin, Sheryl McDiarmid, Michael Kennah, Harold Atkins, Natasha K. Kekre

Blood (2023) 142 (Supplement 1): 6923.

https://doi.org/10.1182/blood-2023-179044

Published: 2023

Journal Articles

Favorable Outcomes with Low Dose Anti Thymocyte Globulin Based Graft Versus Host Disease Prophylaxis after Mismatched Unrelated Donor Allogenic Hematopoietic Cell Transplantation

Hafsah Chalchal, Vinita Dhir, Kalina Abrol, Michelle Boyce, Michelle Delbaere, Ashish Masurekar, Mike Kennah, Natasha K. Kekre, Harold Atkins, Christopher Bredeson, David S. Allan, Ram Vasudevan Nampoothiri

Blood (2023) 142 (Supplement 1): 7002.

https://doi.org/10.1182/blood-2023-182274

Published: 2023

Journal Articles

Intermediate Vs High Dose Busulfan-Based Conditioning for Allogeneic Cell Transplantation in Patients with Acute Leukemia or Myelodysplastic Syndromes from HLA Matched Related or Unrelated Donors: Achieving the Same with Less

Mohamad Sobh, PharmD, Lothar B. Huebsch, MD, Mitchell Sabloff, MSc,MDFRCPC, Jill Fulcher, MDPhDMRCPI FRCPath(UK), Sultan Altouri, MDFRCPC, Michael Kennah, MD, Elizabeth Drouin, MD, David S. Allan, MD FRCPC, MSc, Harold Atkins, MD, Grace Christou, MD, Pierre Villeneuve, MD PhD, Alexandre P.Blanchard, PhD, Kelsey Maclellan, Ranjeeta Mallick, PhD MSc, BSc, Nicole B. Laferriere, MD PhD, Sathish Gopalakrishnan, MD, Sita D. Bhella, MD, Natasha Kekre, MDFRCPC, Christopher Bredeson, MDFRCPC,MSc

Blood (2019) 134 (Supplement_1): 3263.

https://doi.org/10.1182/blood-2019-122436

Published: 2019

Journal Articles

Building Capacity for Relapsed/Refractory ALL Patients Needing CAR-T Cells: How Do We Prepare?

Roy Khalife, MD, Joshua Montroy, MSc, Wasithep Limvorapitak, MD, Raewyn Broady, MBChB, Dean Fergusson, PhD, Harold Atkins, MD, Robert Holt, PhD, Manoj Lalu, MD PhD FRCPC, Natasha Kekre, MD FRCPC

Blood (2018) 132 (Supplement 1): 5159.

https://doi.org/10.1182/blood-2018-99-116879

Published: 2018

Journal Articles

Complications and Toxicities Associated with Autologous Stem Cell Transplantation for Severe Autoimmune Diseases: Single Center Experience

Shona Philip, BSc, MSc, MD, Christopher Bredeson, MD FRCPC, MSc, David S. Allan, MD FRCPC, MSc, Sultan Altouri, MD FRCPC, Lothar B. Huebsch, MD, Harold Atkins, MD, Natasha Kekre, MD FRCPC

Blood (2018) 132 (Supplement 1): 4624.

https://doi.org/10.1182/blood-2018-99-119797

Published: 2018

Journal Articles

Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant

Adam Bryant, MD, Ranjeeta Mallick, Lothar B. Huebsch, MD, David S. Allan, MD FRCPC, Harold Atkins, MDFRCPC, Grizel Anstee, MD, Isabelle Bence-Bruckler, MD FRCPC, Linda Hamelin, Michael Hodgins, MD, Mitchell Sabloff, MDM, Nicholas Scrivens, Dawn C. Maze, MDFRCPC,MSc, Christopher N. Bredeson, MD MSc, FRCPC, Natasha Kekre, MDMPH, FRCPC

Blood (2016) 128 (22): 5782.

https://doi.org/10.1182/blood.V128.22.5782.5782

Published: 2016

Journal Articles

Allogeneic Stem Cell Transplantation for Multiple Myeloma: a Single Center Experience

Amarilis Figueiredo, MD, Harold Atkins, MDFRCPC, Natasha Kekre, MDMPH, FRCPC, Andrea Kew, MD, Arleigh McCurdy, MD

Blood (2016) 128 (22): 5874.

https://doi.org/10.1182/blood.V128.22.5874.5874

Published: 2016

Journal Articles

Factors Influencing Long-Term Hematopoietic Function Following Autologous Stem Cell Transplantation

Alissa Visram, MD, Natasha Kekre, MD MPH, FRCPC, Christopher N. Bredeson, MD MSc, FRCPC, Jason Tay, MDFRCPC MSc, Lothar B. Huebsch, MD, Sheryl McDiarmid, Ranjeeta Mallick, PhD, Mitchell Sabloff, MDM, Harold Atkins, MDFRCPC, David S. Allan, MD FRCPC, Alan Tinmouth, MD FRCPC, Linda Hamelin, Lisa Martin, Dawn Maze, MD FRCPC MSc

Blood (2016) 128 (22): 2186.

https://doi.org/10.1182/blood.V128.22.2186.2186

Published: 2016

Journal Articles

A Comparison of Cyclophosphamide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Amarilis Figueiredo, MD, Harold Atkins, MD FRCPC, Ranjeeta Mallick, PhD, Natasha Kekre, MD MPH, FRCPC, Andrea Kew, MD, Arleigh McCurdy, MD

Blood (2016) 128 (22): 4519.

https://doi.org/10.1182/blood.V128.22.4519.4519

Published: 2016

Journal Articles

Autologous Stem Cell Transplant for Myasthenia Gravis: A Single-Centre Experience

Adam Bryant, MD, Elizabeth Pringle, MD, Christopher Bredeson, MD MSc, FRCPC, David S. Allan, MD MSc, Grizel Anstee, Isabelle Bence-Bruckler, Linda Hamelin, Harry Spencer Hopkins, Lothar B. Huebsch, MD, Mitchell Sabloff, MDM, Dawn C. Sheppard, MDFRCPC,MSc, Jason Tay, MD MSc, Harold Atkins, MD

Blood (2014) 124 (21): 3996.

https://doi.org/10.1182/blood.V124.21.3996.3996

Published: 2014

NARROW

CAR-T Therapy for the Treatment of Relapsed/Refractory CD19 Positive Large B Cell Lymphoma: Canadian Real-World Evidence

Favorable Outcomes with Low Dose Anti Thymocyte Globulin Based Graft Versus Host Disease Prophylaxis after Mismatched Unrelated Donor Allogenic Hematopoietic Cell Transplantation

Intermediate Vs High Dose Busulfan-Based Conditioning for Allogeneic Cell Transplantation in Patients with Acute Leukemia or Myelodysplastic Syndromes from HLA Matched Related or Unrelated Donors: Achieving the Same with Less

Building Capacity for Relapsed/Refractory ALL Patients Needing CAR-T Cells: How Do We Prepare?

Complications and Toxicities Associated with Autologous Stem Cell Transplantation for Severe Autoimmune Diseases: Single Center Experience

Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant

Allogeneic Stem Cell Transplantation for Multiple Myeloma: a Single Center Experience

Factors Influencing Long-Term Hematopoietic Function Following Autologous Stem Cell Transplantation

A Comparison of Cyclophosphamide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Autologous Stem Cell Transplant for Myasthenia Gravis: A Single-Centre Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only